Please assess the completion status of the following clinical trial:

Trial Title: Moderated Blood Flow Restriction After Anterior Cruciate Ligament Reconstruction

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients between 18-30 years of age.~* Diagnosis of isolated anterior cruciate ligament (ACL) tear and pending ACL reconstruction.~Exclusion Criteria:~* age \<18 years old or \>30 years old~* Multi-ligament knee injury~* Revision ACL reconstruction~* History or peripheral vascular disease~* History of deep vein thrombosis or pulmonary embolism~* Any contraindication to moderated blood flow restriction therapy~* Inability to comply with post-operative ACL reconstruction rehabilitation~* If meniscal repair or a cartilage procedure is performed at the time of surgery that would preclude the patient from being able to follow the standard post-operative ACL rehabilitation.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 30 Years
- Healthy Volunteers: f

Study Arms:
- Standard rehabilitation (Type: ACTIVE_COMPARATOR): Patients will receive standard post-operative ACL rehabilitation
- Delfi moderated blood flow restriction (Type: EXPERIMENTAL): Patients will receive Delfi moderated blood flow post-operative ACL rehabilitation

Based on this trial design, predict the completion outcome and termination type (if applicable).